logo
Nakamoto Holdings Appoints Tyler Evans as Chief Investment Officer to Lead Bitcoin-Native Capital Deployment

Nakamoto Holdings Appoints Tyler Evans as Chief Investment Officer to Lead Bitcoin-Native Capital Deployment

Business Wire5 hours ago

NASHVILLE, Tenn.--(BUSINESS WIRE)--Nakamoto Holdings Inc. ('Nakamoto'), a Bitcoin-native holding company, which previously announced its anticipated merger with Kindly MD, Inc. (NASDAQ: NAKA) ('KindlyMD'), today announced the appointment of Tyler Evans as Chief Investment Officer. Building on his six-year track record at UTXO Management, Tyler will lead the strategy and execution of Nakamoto's Bitcoin reserve deployment by originating and structuring deals across capital markets to grow the company's balance sheet and drive long-term shareholder value.
Tyler brings over a decade of experience building Bitcoin-native financial infrastructure. He is a Co-Founder and Chief Investment Officer of UTXO Management, a thesis-driven, high-conviction investment firm focused on the Bitcoin ecosystem and ranked as the fifth best-performing single-manager hedge fund in 2024 by HFR. He has led capital deployment across both early-stage venture and hedge fund strategies, building one of the most active investment portfolios in the Bitcoin industry. Tyler is also a Co-Founder of BTC Inc, publisher of Bitcoin Magazine and host of the annual Bitcoin Conference.
While Tyler will continue in his leadership role at UTXO Management, his appointment as CIO of Nakamoto Holdings reflects a distinct mandate to advance Nakamoto's capital strategy and long-term vision. His active presence across both organizations brings valuable perspective and network synergies that ultimately serve the interests of shareholders of both firms.
'Tyler has been a cornerstone of Bitcoin's story from the very beginning – from media and venture to asset management and public market strategy,' said David Bailey, Founder and CEO of Nakamoto. 'In addition to being a world-class investor, Tyler is a mission-driven leader with deep conviction in Bitcoin and the global experience to back it up. Bringing him on as CIO sets the tone for the bold, Bitcoin-native, and uncompromising future we are building at Nakamoto.'
Tyler added, 'Joining Nakamoto presents an opportunity to redefine how institutional capital interacts with Bitcoin. We are entering an era where Bitcoin is powering corporate growth, treasury management, and global investment strategy. I am thrilled to join David and the Nakamoto team as we help shape that future alongside UTXO Management.'
Tyler currently serves on the boards of Metaplanet Inc. (3350:TSE), Smarter Web Company (SWC.AQ), and Matador (TSX:MATA.V), and LX Research. In addition to his investing work, Tyler mentors early-stage founders through the Bitcoin Startup Lab and Draper BitcoinFi Accelerator, shaping the next generation of innovation across the Bitcoin ecosystem.
About Nakamoto
Nakamoto is a Bitcoin treasury company building a global portfolio of Bitcoin-native companies. Nakamoto plans to establish the first publicly traded conglomerate of Bitcoin companies by accumulating Bitcoin in its treasury and by leveraging its treasury to acquire and develop an ecosystem of Bitcoin companies across finance, media, advisory and more. The company aims to provide commercial and financial infrastructure for the next generation of capital markets. For more information, please visit nakamoto.com.
Forward-Looking Statements
All statements, other than statements of historical fact, included in this release that address activities, events or developments that Kindly MD or Nakamoto expects, believes or anticipates will or may occur in the future are forward-looking statements. Words such as 'estimate,' 'project,' 'predict,' 'believe,' 'expect,' 'anticipate,' 'potential,' 'create,' 'intend,' 'could,' 'would,' 'may,' 'plan,' 'will,' 'guidance,' 'look,' 'goal,' 'future,' 'build,' 'focus,' 'continue,' 'strive,' 'allow' or the negative of such terms or other variations thereof and words and terms of similar substance used in connection with any discussion of future plans, actions, or events identify forward-looking statements. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements include, but are not limited to, statements regarding the proposed merger and related transactions, (collectively, the 'Transactions') the expected closing of the proposed Transactions and the timing thereof and as adjusted descriptions of the post-transaction company and its operations, strategies and plans, integration, debt levels and leverage ratio, capital expenditures, cash flows and anticipated uses thereof, synergies, opportunities and anticipated future performance, including the management team and board of directors of the combined company and expected use of proceeds from the Transactions, and any post-closing transactions contemplated between the combined company and BTC Inc (and/or UTXO, LLC through BTC Inc). Information adjusted for the proposed Transactions should not be considered a forecast of future results. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this release. These include the risk that Kindly MD and Nakamoto businesses (which may include the businesses of BTC Inc and/or UTXO in the future, as applicable) will not be integrated successfully and the risk that Kindly MD or the applicable governing bodies of BTC Inc and/or UTXO may not pursue or approve the terms of an acquisition of BTC Inc and/or UTXO; the risk that cost savings, synergies and growth from the proposed transaction may not be fully realized or may take longer to realize than expected; the possibility that shareholders of Kindly MD may not approve the issuance of new shares of Kindly MD common stock in the Transactions or that shareholders of Kindly MD may not approve the Transactions; the risk that a condition to closing of the Transactions may not be satisfied, that either party may terminate the merger agreement, the subscription agreements of the convertible debt purchase agreement or that the closing of the Transactions might be delayed or not occur at all; potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the Transactions; the parties do not receive regulatory approval of the Transactions; the occurrence of any other event, change, or other circumstances that could give rise to the termination of the merger agreement relating to the Transactions; the risk that changes in Kindly MD's capital structure and governance could have adverse effects on the market value of its securities; the ability of Kindly MD and Nakamoto to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on Kindly MD and Nakamoto's operating results and business generally; the risk the Transactions could distract management from ongoing business operations or cause Kindly MD and/or Nakamoto to incur substantial costs; the risk that Kindly MD may be unable to reduce expenses or access financing or liquidity; the impact of any related economic downturn; the risk of changes in governmental regulations or enforcement practices; and other important factors that could cause actual results to differ materially from those projected. All such factors are difficult to predict and are beyond Kindly MD's and Nakamoto's control, including those detailed in Kindly MD's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and such other documents of Kindly MD filed, or to be filed, with the SEC that are or will be available on Kindly MD's website at www.kindlymd.com and on the website of the SEC at www.sec.gov. All forward-looking statements are based on assumptions that Kindly MD and Nakamoto believe to be reasonable but that may not prove to be accurate. Any forward-looking statement speaks only as of the date on which such statement is made, and neither Kindly MD or Nakamoto undertakes any obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Jennifer Garner's baby food company confidentially files for an IPO, sources say
Jennifer Garner's baby food company confidentially files for an IPO, sources say

Yahoo

time15 minutes ago

  • Yahoo

Jennifer Garner's baby food company confidentially files for an IPO, sources say

By Echo Wang and Abigail Summerville (Reuters) -Once Upon a Farm, the organic baby food company co-founded by actor Jennifer Garner, has filed confidentially for an initial public offering in New York, according to people familiar with the matter. The Berkeley, California-based company has tapped a group of investment banks for the IPO, which could occur as soon as this year, said the sources, who cautioned that the plans could change, depending on market conditions. Goldman Sachs and JPMorgan are the lead underwriters, said the sources, who requested anonymity because the plans are confidential. The offering could value the company at about $1 billion, one of the persons said. Once Upon a Farm did not immediately respond to a request for comment, Goldman Sachs and JPMorgan declined to comment. Garner is known for her work in the TV drama "Alias" and films including "Dallas Buyers Club" and "Catch Me If You Can." A mother of three, she has said she cares deeply about childhood nutrition, and she grows some produce for Once Upon a Farm on her family's century-old farm in Oklahoma. Once Upon a Farm was founded in 2015 by Cassandra Curtis and Ari Raz to create more nutritious baby-food options. In 2017, Garner and John Foraker, the former CEO of food brand Annie's, joined the company as co-founders. The company's products for babies, toddlers and children range from oat bars to cold-pressed pouches and frozen meals, and they are sold in supermarkets across the U.S. An IPO for the company would build on momentum for market debuts in the U.S., a sector that has lately thawed after the Trump administration's tariff announcements earlier this year cast a chill. So far this year, IPOs listed in the U.S. have raised about $27 billion, down from $41 billion in the same period last year, according to data compiled by Dealogic. But this year's figure is more than in 2022 and 2023, when IPOs raised $22 billion and $24 billion, respectively, over the same time frame, according to Dealogic. In its Nasdaq debut last week, digital bank Chime jumped 59%, valuing the company at $18.4 billion. The stock of stablecoin issuer Circle Internet Group climbed to $103.75 and was halted several times for volatility during a wild first day of trading earlier this month. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

SINOVAC Board of Directors Files Definitive Proxy Materials
SINOVAC Board of Directors Files Definitive Proxy Materials

Business Wire

time17 minutes ago

  • Business Wire

SINOVAC Board of Directors Files Definitive Proxy Materials

BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (' SINOVAC ' or the ' Company '), a leading provider of biopharmaceutical products in China, today announced it has filed its definitive proxy materials with the Securities and Exchange Commission (SEC) for the Special Meeting of Shareholders to be held on Wednesday, July 9, 2025 at 8:00 a.m. China Standard Time (Tuesday, July 8, 2025 at 8:00 p.m. Atlantic Standard Time). In conjunction with the filing of the definitive proxy statement, SINOVAC's Board of Directors mailed a letter to shareholders. In that letter, the SINOVAC Board urged valid shareholders to keep SINOVAC's Board in place and vote on the WHITE proxy card ' AGAINST ' Proposal 1 to remove the current Board and ' AGAINST ' Proposal 2 to appoint the Reconstituted Imposter Former Board Slate. While a dissenting investor group led by Advantech/Prime Success and Vivo Capital (together known as the 'Dissenting Investor Group') is attempting to distract shareholders with false claims and empty promises as part of a hostile attempt to remove the SINOVAC Board and entrench themselves, the SINOVAC Board is committed to restoring fairness and delivering value to ALL SINOVAC shareholders. Your Vote is Important Your vote on or before July 8 will be about the future of SINOVAC, your receipt of your make whole dividend payments in the near-term, and the long-term value of your investment. We urge you to keep SINOVAC's Board in place and vote on the WHITE proxy card ' AGAINST ' Proposal 1 to remove the current Board and ' AGAINST ' Proposal 2 to appoint the Reconstituted Imposter Board Slate. Your vote is critical to ensuring that SINOVAC remains on the path to stability, growth, and value creation for all shareholders. DISCARD any items you received asking you to vote for the Reconstituted Imposter Former Board Slate. If you have already voted for the Reconstituted Imposter Former Board Slate, you can subsequently revoke it by using the WHITE proxy card or WHITE voting instruction form to vote. Only your latest-dated vote will count! If you have questions about how your vote can be counted, please contact our proxy solicitor, Georgeson LLC, toll free at (844) 568-1506 in the U.S and (646) 543-1968 outside the U.S. or via email at SinovacSpecialMeeting@ About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. Important Additional Information and Where to Find It In connection with SINOVAC's Special Meeting, SINOVAC has filed with the U.S. Securities and Exchange Commission ('SEC') and mailed to shareholders of record entitled to vote at the Special Meeting a definitive proxy statement and other documents, including a WHITE proxy card. SHAREHOLDERS ARE ENCOURAGED TO READ THE PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS WHEN FILED WITH THE SEC AND WHEN THEY BECOME AVAILABLE BECAUSE THOSE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and other interested parties will be able to obtain the documents free of charge at the SEC's website, or from SINOVAC at its website: You may also obtain copies of SINOVAC's definitive proxy statement and other documents, free of charge, by contacting SINOVAC's Investor Relations Department at ir@ Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'may,' 'will,' 'expect,' 'anticipate,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to' or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's or Board's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

Houston Ship Channel Expansion – Project 11 Funded to Completion
Houston Ship Channel Expansion – Project 11 Funded to Completion

Business Wire

time22 minutes ago

  • Business Wire

Houston Ship Channel Expansion – Project 11 Funded to Completion

HOUSTON--(BUSINESS WIRE)--Port Houston is pleased the President's fiscal year (FY) 2026 budget has allocated $161 million for the Houston Ship Channel Expansion – Project 11. In addition, the President's FY26 Operation & Maintenance (O&M) budget allocated $53.6 million to the Houston Ship Channel, the nation's No. 1 ranked waterway. These funds are in addition to the $33 million for Project 11 construction and $98 million for O&M in the U.S. Army Corps of Engineers (USACE) Workplan for FY25 that was released a few weeks ago. Port Houston is pleased that the President's fiscal year (FY) 2026 budget has allocated $161 million for the Houston Ship Channel Expansion – Project 11. Share Port Houston Chairman Ric Campo extended congratulations and appreciation to all industry partners, stakeholders, Congressman Wesley Hunt, and the bipartisan delegation involved in this tremendous effort undertaken over the past several years. "This is a momentous achievement," said Chairman Campo. "We appreciate the Trump Administration for recognizing the criticality of this expansion and applaud Congressman Wesley Hunt and Congressman Brian Babin for their tremendous advocacy and unwavering leadership to bring home the millions of federal dollars needed to complete Project 11. This project will keep our economy moving forward and enable our port to continue delivering for not just Houstonians but the entire nation." "Since my swearing-in nearly three years ago, one of my biggest priorities has been to ensure that Project 11 in the Houston Ship Channel is fully funded and its construction completed. As the largest energy port in the entire world, Project 11's success is essential to maintaining Texas's and the United States' energy dominance," said Congressman Hunt. 'I would also like to express my sincerest gratitude to President Trump for recognizing the importance of this project and his goal of ensuring America is once again a net exporter of energy." Project 11 Construction Progress Several portions of the channel expansion project are complete and already providing benefits. Daylight restrictions have been reduced by up to two hours in each direction, increasing time for two-way vessel traffic along the waterway and improving efficiency. Later this summer Port Houston will complete the remaining Port-led portion of Project 11 dredging, between Bayport Ship Channel and Barbours Cut Ship Channel, with USACE leading the remaining portions of Project 11 in Barbours Cut and the upper Turning Basin. Project 11 is scheduled to be complete by 2029. Project 11 is a testament to Port Houston's advocacy for the Houston Ship Channel and the region. It will provide a safer waterway for larger ships and vessels, further supporting economic development and jobs for the region and the state of Texas. See more details and updates about Houston Ship Channel Expansion – Project 11 here: For more than 100 years, Port Houston has owned and operated the public wharves and terminals along the Houston Ship Channel, including the area's largest breakbulk facility and two of the most efficient container terminals in the country. Port Houston is the advocate and a strategic leader for the Channel. The Houston Ship Channel complex and its more than 200 private and eight public terminals is the nation's largest port for waterborne tonnage and an essential economic engine for the Houston region, the state of Texas and the U.S. The Port of Houston supports the creation of nearly 1.5 million jobs in Texas and 3.37 million jobs nationwide, and economic activity totaling $439 billion in Texas and $906 billion in economic impact across the nation. For more information, visit the website at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store